银河
发表于 2025-3-21 19:06:08
书目名称Cellular Engineering and Cellular Therapies影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0223023<br><br> <br><br>书目名称Cellular Engineering and Cellular Therapies读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0223023<br><br> <br><br>
Clumsy
发表于 2025-3-21 23:25:14
http://reply.papertrans.cn/23/2231/223023/223023_2.png
捕鲸鱼叉
发表于 2025-3-22 00:29:56
http://reply.papertrans.cn/23/2231/223023/223023_3.png
染色体
发表于 2025-3-22 06:52:42
http://reply.papertrans.cn/23/2231/223023/223023_4.png
沉思的鱼
发表于 2025-3-22 11:37:24
Informationsmanagement und Controllingsecondary lymphoid organs, and other tissues in which T cell generation and proliferation take place. The composite impact of these factors leads to T cell immunodeficiency following allogeneic HSCT, which can contribute to unacceptably high rates of opportunistic infection and relapse. Improving th
唠叨
发表于 2025-3-22 13:03:31
http://reply.papertrans.cn/23/2231/223023/223023_6.png
唠叨
发表于 2025-3-22 20:45:24
The New Regulatory Environment for Cellular Therapy Products: Challenges for Academic-Based Manufactd proposed regulations relevant to cellular therapy products. These new expectations have created substantial challenges for manufacturers, especially for academic-based laboratories that support early phase clinical trials not intended to result in a commercial product.
宿醉
发表于 2025-3-23 01:01:10
Cell Manipulation and Engineering — State of the Art and Future Developmentsused for current good manufacturing practice (cGMP) be applied. With the advent of embryonic stem cell research and the literal explosion in new cellular tissues and components, the cGMP format became nearly unobtainable by most academic centers due to cost, physical requirements and regulatory/admi
magnanimity
发表于 2025-3-23 03:30:47
Factors Controlling Expansion and Maturation of Haematopoietic Progenitor Cellsn be used to generate large quantities of more mature progenitor cells, and a number of clinical studies have shown promising results . During culture with cytokines, cells go through different stages of the cell cycle and the expression of cell surface adhesion molecules is altered; both fact
Fatten
发表于 2025-3-23 07:26:47
Reconstituting T Cell Immunity Following Hematopoietic Stem Cell Transplantationsecondary lymphoid organs, and other tissues in which T cell generation and proliferation take place. The composite impact of these factors leads to T cell immunodeficiency following allogeneic HSCT, which can contribute to unacceptably high rates of opportunistic infection and relapse. Improving th